Text4Vax: Text Message Reminders for Pediatric COVID-19 and Influenza Vaccines 2024-25 Season
NCT ID: NCT06603090
Last Updated: 2025-07-11
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
66147 participants
INTERVENTIONAL
2024-10-02
2025-04-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Text Message Reminder-Recalls For Early Childhood Vaccination
NCT01199666
Screening for Hesitancy to Optimize Talk
NCT02708745
SMS HPV Vaccine Reminders
NCT05151367
Immunogenicity and Safety of a Quadrivalent Meningococcal Conjugate Vaccine When Administered Concomitantly With Routine Pediatric Vaccines in Healthy Infants and Toddlers in the US
NCT03537508
Study of a Tetravalent Meningococcal Diphtheria Toxoid Conjugate Vaccine in Toddlers 9 to 18 Months of Age
NCT00643916
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Randomization is to be stratified by practice site, age group and prior year's COVID-19/influenza vaccine history. Messages will be sent centrally and managed by the research team.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
HEALTH_SERVICES_RESEARCH
TRIPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Text message influenza and COVID-19 vaccine reminders
Text message reminders for both influenza and COVID-19 vaccinations
Text message influenza and COVID-19 vaccine reminders
Text message influenza and COVID-19 vaccine reminders
Text message influenza vaccine reminders
Text message reminders only for influenza vaccination
Text message influenza vaccine reminders
Text message influenza vaccine reminders
Text message COVID-19 vaccine reminders
Text message reminders only for COVID-19 vaccination
Text message COVID-19 vaccine reminders
Text message COVID-19 vaccine reminders
Usual Care
Usual care has no text message
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Text message influenza vaccine reminders
Text message influenza vaccine reminders
Text message COVID-19 vaccine reminders
Text message COVID-19 vaccine reminders
Text message influenza and COVID-19 vaccine reminders
Text message influenza and COVID-19 vaccine reminders
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* is 6 months-17 year-old children
* due for both a COVID-19 and influenza vaccine
* Receives care at study site
* Language listed in electronic health record is English or Spanish
* Has not opted out of text messages from practice
Exclusion Criteria
* Language listed in electronic health record is not English or Spanish
6 Months
17 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Children's Hospital of Philadelphia
OTHER
American Academy of Pediatrics
OTHER
University of Pennsylvania
OTHER
National Institute of Allergy and Infectious Diseases (NIAID)
NIH
Columbia University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Melissa Stockwell
Professor of Pediatrics; Professor of Population and Family Health
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Melissa Stockwell, MD MPH
Role: PRINCIPAL_INVESTIGATOR
Columbia University
Alex Fiks, MD MSCE
Role: PRINCIPAL_INVESTIGATOR
Children's Hospital of Philadelphia
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
American Academy of Pediatrics
Itasca, Illinois, United States
Columbia University Irving Medical Center
New York, New York, United States
Children's Hospital of Philadelphia
Philadelphia, Pennsylvania, United States
University of Pennsylvania
Philadelphia, Pennsylvania, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
AAAV0563-01
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.